Frederic Menard

Title: Frederic Menard: Innovator in Sodium Channel Modulation

Introduction

Frederic Menard is a notable inventor based in Menlo Park, CA (US). He has made significant contributions to the field of pharmacology, particularly in the development of compounds that modulate sodium channels. With a total of 2 patents, his work has implications for treating various medical conditions.

Latest Patents

Menard's latest patents include innovative compounds related to batrachotoxin and aconitine. The first patent focuses on batrachotoxin analogues, which are designed to modulate the activity of sodium channels. These compounds are formulated into pharmaceutical compositions that can be used to reduce neuronal activity or induce muscular relaxation. They are particularly beneficial for treating ailments associated with voltage-gated sodium channels and pain management. The second patent involves aconitine derivatives, which similarly modulate sodium channel activity and are also aimed at treating conditions related to neuronal activity and muscular relaxation.

Career Highlights

Frederic Menard is affiliated with Leland Stanford Junior University, where he conducts research and development in pharmacological innovations. His work is characterized by a strong focus on the therapeutic applications of sodium channel modulators.

Collaborations

Menard collaborates with esteemed colleagues such as Justin Du Bois and Matthew M Logan, contributing to a dynamic research environment that fosters innovation.

Conclusion

Frederic Menard's contributions to the field of pharmacology through his patents on sodium channel modulators highlight his role as a significant inventor. His work continues to pave the way for advancements in medical treatments.